发明名称 |
USE OF CO-RELEASING COMPOUNDS FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF INFLAMMATORY DISEASES |
摘要 |
<p>Several classes of in vivo carbon monoxide-releasing compounds are useful for the treatment and/or prevention of diseases, such as chronic inflammatory, e.g. rheumatoid arthritis, and of diseases with a strong inflammatory component, such as atherosclerosis, stroke, coronary disease, and Alzheimers disease. The in vivo carbon monoxide-releasing compounds can be attached to known drug vectors and/or known anti-inflammatory drugs, such as aspirin.</p> |
申请公布号 |
EP1476168(A2) |
申请公布日期 |
2004.11.17 |
申请号 |
EP20030706818 |
申请日期 |
2003.02.03 |
申请人 |
ALFAMA-INVESTIGACAO E DESENVOLVIMENTO DE PRODUTOS FARMACEUTICOS LDA. |
发明人 |
HAAS, WERNER;ROMAO, CARLOS;ROYO, BEATRIZ;FERNANDES, ANA CRISTINA;GONCALVES, ISABEL |
分类号 |
A61K33/26;A61K45/00;A61K9/127;A61K31/00;A61K31/18;A61K31/192;A61K31/28;A61K31/555;A61K31/60;A61K31/603;A61K31/616;A61K31/695;A61K31/7048;A61K31/7135;A61K33/00;A61K33/14;A61K33/32;A61K45/06;A61K47/48;A61P9/00;A61P9/10;A61P11/06;A61P25/28;A61P29/00;C07F11/00;C07F13/00;C07F15/02;C07F17/00;(IPC1-7):A61K31/704;A61K31/713 |
主分类号 |
A61K33/26 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|